PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
02-Mar-2022 Thermo Fisher Scientific’s PPD Clinical Research Business Earns Honor for Employee Development Driving Customer Success PPD
02-Mar-2022 Vetter’s Extraordinary Performance Sweeps the Board at the 2022 CMO Leadership Awards B3C newswire
02-Mar-2022 Product Development Company MiGenTra Announces Formation of International Advisory Board MiGenTra
02-Mar-2022 Latest LPLDL® human intervention study from ProBiotix Health highlights ‘promising findings’ on cholesterol reduction ProBiotix Health
02-Mar-2022 “Hotspot mapping” accelerates early-phase drug design Cambridge Crystallographic Data Centre (CCDC)
02-Mar-2022 Product Development Company MiGenTra Announces Formation of International Advisory Board B3C newswire
02-Mar-2022 Gilead Receives Complete Response Letter From U.S. FDA for Investigational Lenacapavir Due to Vial Compatibility Issues Gilead
02-Mar-2022 Jardiance® provided a significant clinical benefit in adults stabilized in hospital following acute heart failure in EMPULSE phase III trial Lilly
02-Mar-2022 HUTCHMED Receives Approval to Commercialize ELUNATE® in Macau HUTCHMED (China) Limited
02-Mar-2022 BioMed X Institute and Boehringer Ingelheim Start New Research Project in Brain Sensor Development BioMed X Institute
02-Mar-2022 Achilles Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Recent Business Highlights Achilles Therapeutics
02-Mar-2022 Novo Holdings Portfolio Company Syndesi Therapeutics acquired by AbbVie Novo Holdings
02-Mar-2022 V-Bio Ventures’ Portfolio Company Syndesi Therapeutics Acquired by AbbVie to Strengthen its Neuroscience Portfolio V-Bio Ventures
02-Mar-2022 StemPrintER Demonstrates Prognostic Utility in TransATAC Cohort Tiziana Life Sciences Ltd
02-Mar-2022 BC Platforms Opens Singapore R&D Center and Signs New Data Partnership to Drive Precision Medicine in Asia Pacific Region BC Platforms
02-Mar-2022 International Society for Cell & Gene Therapy establishes working group to tackle regulatory and ethical issues with Expanded Access International Society for Cell & Gene Therapy
02-Mar-2022 Glucophage® is the First Oral Diabetes Treatment Approved in Europe for use during Pregnancy Merck
02-Mar-2022 Santhera Signs Gene Therapy Agreement with SEAL Therapeutics Santhera Pharmaceuticals
02-Mar-2022 Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodialysis patients Vifor Pharma Group
02-Mar-2022 Late-breaking data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly improved signs and symptoms of eosinophilic esophagitis Sanofi